abstract |
The present invention relates to dosage forms comprising enzalutamide, wherein the enzalutamide is present in a dissolved form. Further, the invention relates to the use of a solvent having a specific HLB -value for producing a water/oil emulsion of an API having water- solubility of 1·10 -3 mg/ml to 1·10 -2 mg/ml. |